RecruitingNot Applicable

Personalized Exercise Treatments for Older Veterans With Motoric Cognitive Risk Syndrome

United States54 participantsStarted 2025-07-01

Plain-language summary

This study will begin to evaluate personalized preventative dementia treatments for Veterans at risk for developing dementia. The investigators will target Veterans with Motoric Cognitive Risk syndrome (MCR), which is characterized by slow gait speed and cognitive concerns (e.g., problems with memory or concentrations).

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 65
✓. Receiving VA primary care
✓. Community-dwelling
✓. Motoric Cognitive Risky Syndrome i. Slow gait speed ii. Subjective cognitive concerns/complaints

Exclusion criteria

✕. Non-English speaking
✕. Presence of a terminal disease
✕. Major medical problem
✕. Myocardial infarction or major surgery in the previous 3 months
✕. 3-point walking pattern
✕. Dementia diagnostic
✕. Mobility disability

What they're measuring

Enrollment/Baseline

Timeframe: Enrollment

Retention

Timeframe: Baseline to end of 12-week treatment

Compliance

Timeframe: Baseline to end of 12-week treatment

Acceptability

Timeframe: End of 12-week treatment

Trial details

NCT IDNCT06451874

SponsorVA Office of Research and Development

Sponsor typeFED

Study typeINTERVENTIONAL

Primary completion2029-05-31

Contact for this trial

Elisa Ogawa, PhD MS BS

(857) 364-4011 elisa.ogawa@va.gov

View on ClinicalTrials.gov More Motoric Cognitive Risk Syndrome trials